1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fate mapping reveals a Cxcr4-dependent immune response of monocytes to experimental stroke
    Meeting Abstract

    Mass, E.; Werner, Y.; Ulas, T.; Handler, K.; Horne, A.; Klee, K.; Kumar, P. A.; Schutz, D.; Saaber, F.; Redecker, C.; more...
    European Journal of Immunology (2019)

    Fulltext@MSK | Save
  • Feasibility of fertility preservation in pre-pubertal males scheduled to receive chemotherapy
    Meeting Abstract

    Bernie, H. L.; Schofield, E.; Benfante, N.; Mulhall, J. P.
    Fertility and Sterility (2019)

    Fulltext@MSK | Save
  • No-scalpel vasectomy: Puncture-first with multi-occlusion technique
    Meeting Abstract

    Kasabwala, K.; Bernie, H. L.; Kim, S. J.; Dudley, V. L.; Goldstein, M.
    Fertility and Sterility (2019)

    Fulltext@MSK | Save
  • Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients
    Meeting Abstract

    Abou-Alfa, G. K.; Harding, J. J.; Awada, A.; Kotecki, N.; Aftimos, P.; Decaens, T.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Serdjebi, C.; more...
    Hepatology (2019)

    Fulltext@MSK | Save
  • Belatacept interference with B-cell cross-matching, consideration for desensitization protocols using co-sitmulatory blockade
    Meeting Abstract

    Blouin, A. G.; Vlad, G.
    Human Immunology (2019)

    Fulltext@MSK | Save
  • Differentiation and tissue-adaptation of type-2 innate lymphoid cells during helminth infection
    Meeting Abstract

    Lian, M.; Zeis, P.; Fan, X.; Symowski, C.; Gentek, R.; Bajenoff, M.; Rudensky, A. Y.; Voehringer, D.; Kastenmuller, W.; Grun, D.; more...
    European Journal of Immunology (2019)

    Fulltext@MSK | Save
  • Large-scale transcriptome-wide association study (TWAS) identifies novel candidate susceptibility genes for pancreatic cancer
    Meeting Abstract

    Zhong, J.; Jermusyk, A.; Wu, L.; Hoskins, J. W.; Collins, I.; Zhang, M.; Lei, S.; Chung, C. C.; Zhang, T.; Xiao, W.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer
    Meeting Abstract

    Zhang, Z.; Karthaus, W.; Mota, J. M.; Mu, P.; Wu, C.; Abida, W.; Linton, E.; Lee, Y. S.; Lee, E.; Mao, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • TATTON phase Ib expansion cohort: Osimertinib plus savolitinib for patients (pts) with EGFR-mutant, MET-amplified NSCLC after progression on prior first/second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)
    Meeting Abstract

    Yu, H.; Ahn, M. J.; Kim, S. W.; Cho, B. C.; Sequist, L.; Orlov, S.; Ottesen, L. H.; Verheijen, R. B.; Mellemgaard, A.; Wessen, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save